| John G Peterson, MD, FACC | |
|
212 E Central Ave, Suite 240, Spokane, WA 99208-6291 | |
| (509) 455-8820 | |
| (509) 838-4978 |
| Full Name | John G Peterson |
|---|---|
| Gender | Male |
| Speciality | Interventional Cardiology |
| Experience | 32 Years |
| Location | 212 E Central Ave, Spokane, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013931997 | NPI | - | NPPES |
| 060056517 | Other | WA | RRB |
| 805511702 | Medicaid | ID | |
| 8240657 | Medicaid | WA |
| Facility Name | Location | Facility Type |
|---|---|---|
| Prov Sacred Hrt Med Ctr & Childs Hosp. | Spokane, WA | Hospital |
| Providence Holy Family Hospital | Spokane, WA | Hospital |
| Providence St Joseph Hospital | Chewelah, WA | Hospital |
| Newport Community Hospital | Newport, WA | Hospital |
| Providence Mount Carmel Hospital | Colville, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Providence Health And Services Washington | 8729258256 | 47 |
News Archive
Merck, known as MSD outside the United States and Canada, and Intercell AG today announced that following a pre-specified interim analysis from the Phase II/III clinical trial evaluating V710, an investigational vaccine for the prevention of Staphylococcus aureus infection, the independent Data Monitoring Committee recommended suspension of enrollment.
The U.S. Food and Drug Administration today expanded the approved use of Exjade (deferasirox) to treat patients ages 10 years and older who have chronic iron overload resulting from a genetic blood disorder called non-transfusion-dependent thalassemia (NTDT).
For decades, scientists have known that DNA consists of four basic units - adenine, guanine, thymine and cytosine. Those four bases have been taught in science textbooks and have formed the basis of the growing knowledge regarding how genes code for life.
The LAP-BAND- weight loss procedure is safe and effective in an expanded group of patients, not just in people who are morbidly obese. This conclusion is reported in a new study published in the scientific journal Obesity. The findings indicate that the procedure may help to intervene before obesity becomes life threatening to patients.
Not all patients with sickle cell disease receive laxatives after being treated with narcotics, despite recommendations from a collaborative panel of pediatric experts. These are the findings from a Nationwide Children's Hospital study examining patients from 29 pediatric hospitals, and appearing in Pediatric Blood & Cancer.
› Verified 7 days ago
| Entity Name | Grant County Public Hospital District 1 |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619086766 PECOS PAC ID: 9931095692 Enrollment ID: O20040227000602 |
News Archive
Merck, known as MSD outside the United States and Canada, and Intercell AG today announced that following a pre-specified interim analysis from the Phase II/III clinical trial evaluating V710, an investigational vaccine for the prevention of Staphylococcus aureus infection, the independent Data Monitoring Committee recommended suspension of enrollment.
The U.S. Food and Drug Administration today expanded the approved use of Exjade (deferasirox) to treat patients ages 10 years and older who have chronic iron overload resulting from a genetic blood disorder called non-transfusion-dependent thalassemia (NTDT).
For decades, scientists have known that DNA consists of four basic units - adenine, guanine, thymine and cytosine. Those four bases have been taught in science textbooks and have formed the basis of the growing knowledge regarding how genes code for life.
The LAP-BAND- weight loss procedure is safe and effective in an expanded group of patients, not just in people who are morbidly obese. This conclusion is reported in a new study published in the scientific journal Obesity. The findings indicate that the procedure may help to intervene before obesity becomes life threatening to patients.
Not all patients with sickle cell disease receive laxatives after being treated with narcotics, despite recommendations from a collaborative panel of pediatric experts. These are the findings from a Nationwide Children's Hospital study examining patients from 29 pediatric hospitals, and appearing in Pediatric Blood & Cancer.
› Verified 7 days ago
| Entity Name | Tri-state Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598814352 PECOS PAC ID: 4082502422 Enrollment ID: O20040308001123 |
News Archive
Merck, known as MSD outside the United States and Canada, and Intercell AG today announced that following a pre-specified interim analysis from the Phase II/III clinical trial evaluating V710, an investigational vaccine for the prevention of Staphylococcus aureus infection, the independent Data Monitoring Committee recommended suspension of enrollment.
The U.S. Food and Drug Administration today expanded the approved use of Exjade (deferasirox) to treat patients ages 10 years and older who have chronic iron overload resulting from a genetic blood disorder called non-transfusion-dependent thalassemia (NTDT).
For decades, scientists have known that DNA consists of four basic units - adenine, guanine, thymine and cytosine. Those four bases have been taught in science textbooks and have formed the basis of the growing knowledge regarding how genes code for life.
The LAP-BAND- weight loss procedure is safe and effective in an expanded group of patients, not just in people who are morbidly obese. This conclusion is reported in a new study published in the scientific journal Obesity. The findings indicate that the procedure may help to intervene before obesity becomes life threatening to patients.
Not all patients with sickle cell disease receive laxatives after being treated with narcotics, despite recommendations from a collaborative panel of pediatric experts. These are the findings from a Nationwide Children's Hospital study examining patients from 29 pediatric hospitals, and appearing in Pediatric Blood & Cancer.
› Verified 7 days ago
| Entity Name | Providence Health & Services - Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841442332 PECOS PAC ID: 3577623115 Enrollment ID: O20090130000176 |
News Archive
Merck, known as MSD outside the United States and Canada, and Intercell AG today announced that following a pre-specified interim analysis from the Phase II/III clinical trial evaluating V710, an investigational vaccine for the prevention of Staphylococcus aureus infection, the independent Data Monitoring Committee recommended suspension of enrollment.
The U.S. Food and Drug Administration today expanded the approved use of Exjade (deferasirox) to treat patients ages 10 years and older who have chronic iron overload resulting from a genetic blood disorder called non-transfusion-dependent thalassemia (NTDT).
For decades, scientists have known that DNA consists of four basic units - adenine, guanine, thymine and cytosine. Those four bases have been taught in science textbooks and have formed the basis of the growing knowledge regarding how genes code for life.
The LAP-BAND- weight loss procedure is safe and effective in an expanded group of patients, not just in people who are morbidly obese. This conclusion is reported in a new study published in the scientific journal Obesity. The findings indicate that the procedure may help to intervene before obesity becomes life threatening to patients.
Not all patients with sickle cell disease receive laxatives after being treated with narcotics, despite recommendations from a collaborative panel of pediatric experts. These are the findings from a Nationwide Children's Hospital study examining patients from 29 pediatric hospitals, and appearing in Pediatric Blood & Cancer.
› Verified 7 days ago
| Entity Name | Providence Health & Services Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881907715 PECOS PAC ID: 8729258256 Enrollment ID: O20110819000034 |
News Archive
Merck, known as MSD outside the United States and Canada, and Intercell AG today announced that following a pre-specified interim analysis from the Phase II/III clinical trial evaluating V710, an investigational vaccine for the prevention of Staphylococcus aureus infection, the independent Data Monitoring Committee recommended suspension of enrollment.
The U.S. Food and Drug Administration today expanded the approved use of Exjade (deferasirox) to treat patients ages 10 years and older who have chronic iron overload resulting from a genetic blood disorder called non-transfusion-dependent thalassemia (NTDT).
For decades, scientists have known that DNA consists of four basic units - adenine, guanine, thymine and cytosine. Those four bases have been taught in science textbooks and have formed the basis of the growing knowledge regarding how genes code for life.
The LAP-BAND- weight loss procedure is safe and effective in an expanded group of patients, not just in people who are morbidly obese. This conclusion is reported in a new study published in the scientific journal Obesity. The findings indicate that the procedure may help to intervene before obesity becomes life threatening to patients.
Not all patients with sickle cell disease receive laxatives after being treated with narcotics, despite recommendations from a collaborative panel of pediatric experts. These are the findings from a Nationwide Children's Hospital study examining patients from 29 pediatric hospitals, and appearing in Pediatric Blood & Cancer.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John G Peterson, MD, FACC Po Box 331, Liberty Lake, WA 99019-0331 Ph: (866) 747-2455 | John G Peterson, MD, FACC 212 E Central Ave, Suite 240, Spokane, WA 99208-6291 Ph: (509) 455-8820 |
News Archive
Merck, known as MSD outside the United States and Canada, and Intercell AG today announced that following a pre-specified interim analysis from the Phase II/III clinical trial evaluating V710, an investigational vaccine for the prevention of Staphylococcus aureus infection, the independent Data Monitoring Committee recommended suspension of enrollment.
The U.S. Food and Drug Administration today expanded the approved use of Exjade (deferasirox) to treat patients ages 10 years and older who have chronic iron overload resulting from a genetic blood disorder called non-transfusion-dependent thalassemia (NTDT).
For decades, scientists have known that DNA consists of four basic units - adenine, guanine, thymine and cytosine. Those four bases have been taught in science textbooks and have formed the basis of the growing knowledge regarding how genes code for life.
The LAP-BAND- weight loss procedure is safe and effective in an expanded group of patients, not just in people who are morbidly obese. This conclusion is reported in a new study published in the scientific journal Obesity. The findings indicate that the procedure may help to intervene before obesity becomes life threatening to patients.
Not all patients with sickle cell disease receive laxatives after being treated with narcotics, despite recommendations from a collaborative panel of pediatric experts. These are the findings from a Nationwide Children's Hospital study examining patients from 29 pediatric hospitals, and appearing in Pediatric Blood & Cancer.
› Verified 7 days ago
Ms. Deirdre Marie Mooney, MD, MPH Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 122 W 7th Ave Ste 450, Spokane, WA 99204 Phone: 509-455-8820 | |
Dr. Rebecca Raluca Teona Muntean, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 820 S Mcclellan St, Suite 200, Spokane, WA 99204 Phone: 509-747-1144 Fax: 509-455-4166 | |
Dr. Arnold L Klipstein, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 801 W 5th Ave Ste 309, Spokane, WA 99204 Phone: 509-838-2531 Fax: 509-755-6580 | |
Dr. Joseph W Davis, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 104 W 5th Ave Ste 200w, Spokane, WA 99204 Phone: 509-744-3750 Fax: 509-744-3969 | |
Elizabeth C Ho, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 546 N Jefferson Ln Ste 200, Spokane, WA 99201 Phone: 509-625-3700 Fax: 509-625-3747 | |
Michael F. Kestell, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 105 W 8th Ave, Suite 6010, Spokane, WA 99204 Phone: 509-838-5950 Fax: 509-838-5961 |